Report suspected side effects through the MHRA Yellow Card Scheme to support ongoing medication safety surveillance
Take berberine shortly before meals or with the first few bites of food
Patients with baseline mood disorders, anxiety, or emotional dysregulation may face higher risk of irritability intensification on GLP-1 therapy
The emotional pattern I see with patients is consistent: they worry about digestive changes, but most keep the medication because the metabolic and weight benefits matter more to them than transient discomfort
Tirzepatide is a once-weekly injectable medication that works by targeting key hormones responsible for appetite regulation and blood sugar balance
As the main problem lies in the lack of endogenous insulin production, all T1DM subjects will have low portal insulin levels, even when treated with subcutaneous insulin, as this will only increase systemic insulin concentrations